Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: Implications for Duchenne muscular dystrophy and Limb-girdle muscular dystrophy-1C

Molecular Biology of the Cell

Volumn 14, Issue 10, 2003, Pages 4075-4088

  Volonte, Daniela ^b   Peoples, Aaron J ^b   Galbiati, Ferruccio ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CAVEOLIN 3;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL FUSION; CELL IMMORTALIZATION; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; GENE OVEREXPRESSION; IN VIVO STUDY; LIMB GIRDLE MUSCULAR DYSTROPHY; MICROTUBULE ASSEMBLY; MODULATION; MOLECULAR MECHANICS; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MYOBLAST; MYOTUBE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SATELLITE CELL; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; CADHERINS; CAVEOLAE; CAVEOLIN 3; CAVEOLINS; CELLS, CULTURED; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MUSCLE FIBERS; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS, SKELETAL;

ANIMALIA; MUS MUSCULUS;

EID: 0141429991     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-03-0161     Document Type: Article

References (66)

1. Bonilla, E., Fishbeck, K., and Schotland, D. (1981). Freeze-fracture studies of muscle caveolae in human muscular dystrophy. Am. J. Pathol. 104, 167-173.
2. Cifuentes-Diaz, C., Goudou, D., Mege, R.M., Velasco, E., Nicolet, M., Herrenknecht, K., Rubin, L., and Rieger, F. (1998). Distinct location and prevalence of alpha-, beta-catenins and gamma-catenin/plakoglobin in developing and denervated skeletal muscle. Cell Adhes. Commun. 5, 161-176.
3. Cooper, R.N., Tajbakhsh, S., Mouly, V., Cossu, G., Buckingham, M., and Butler-Browne, G.S. (1999). In vivo satellite cell activation via Myf5 and MyoD in regenerating mouse skeletal muscle. J. Cell Sci. 112(Pt 17), 2895-2901.
4. Cornelison, D.D., and Wold, B.J. (1997). Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191, 270-283.
5. Cossu, G., and Mavilio, F. (2000). Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J. Clin. Invest. 105, 1669-1674.
6. Couet, J., Li, S., Okamoto, T., Scherer, P.S., and Lisanti, M.P. (1997). Molecular and cellular biology of caveolae: paradoxes and plasticities. Trends Cardiovasc. Med. 7, 103-110.
7. Crosbie, R.H., Yamada, H., Venzke, D.P., Lisanti, M.P., and Campbell, K.P. (1998). Caveolin-3 is not an essential component of the dystrophin glycoprotein complex. FEBS Lett. 427, 279-282.
8. Deconinck, N., Ragot, T., Marechal, G., Perricaudet, M., and Gillis, J.M. (1996). Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. USA 93, 3570-3574.
9. Ehler, E., Jat, P.S., Noble, M.D., Citi, S., and Draeger, A. (1995). Vascular smooth muscle cells of H-2Kb-tsA58 transgenic mice. Characterization of cell lines with distinct properties. Circulation 92, 3289-3296.
10. Engelman, J.A., Chu, C., Lin, A., Jo, H., Ikezu, T., Okamoto, T., Kohtz, D.S., and Lisanti, M.P. (1998a). Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428, 205-211.
11. Engelman, J.A. et al. (1998b). Reciprocal regulation of Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for mammary tumorigenesis. J. Biol. Chem. 273, 20448-20455.
12. Engelman, J.A., Zhang, X.L., Razani, B., Pestell, R.G., and Lisanti, M.P. (1999). p42/44 MAP kinase-dependent and -independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J. Biol. Chem. 274, 32333-32341.
13. Galbiati, F. et al. (2001a). Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J. Biol. Chem. 276, 21425-21433.
14. Galbiati, F., Volonte, D., Brown, A.M., Weinstein, D.E., Ben-Ze'ev, A., Pestell, R.G., and Lisanti, M.P. (2000a). Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J. Biol. Chem. 275, 23368-23377.
15. Galbiati, F. et al. (2000b). Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc. Natl. Acad. Sci. USA 97, 9689-9694.
16. Galbiati, F., Volonte, D., Engelman, J.A., Scherer, P.E., and Lisanti, M.P. (1999a). Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J. Biol. Chem. 274, 30315-30321.
17. Galbiati, F., Volonte, D., Liu, J., Capozza, F., Frank, P.G., Zhu, L., Pestell, R.G., and Lisanti, M.P. (2001b). Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol. Biol. Cell 12, 2229-2244.
18. Galbiati, F., Volonte, D., Minetti, C., Bregman, D.B., and Lisanti, M.P. (2000c). Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutants and rescues wild-type caveolin-3. J. Biol. Chem. 275, 37702-37711.
19. Galbiati, F., Volonte, D., Minetti, C., Chu, J.B., and Lisanti, M.P. (1999b). Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. J. Biol. Chem. 274, 25632-25641.
20. Garcia-Cardena, G., Martasek, P., Masters, B.S., Skidd, P.M., Couet, J., Li, S., Lisanti, M.P., and Sessa, W.C. (1997). Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J. Biol. Chem. 272, 25437-25440.
21. Garcia-Cardena, G., Oh, P., Liu, J., Schnitzer, J.E., and Sessa, W.C. (1996). Targeting of nitric oxide synthase to endothelilal cell caveolae via palmitoylation: implications for caveolae localization. Proc. Natl. Acad. Sci. USA 93, 6448-6453.
22. Geiger, B., and Ayalon, O. (1992). Cadherins. Annu. Rev. Cell Biol. 8, 307-332.
23. Grounds, M.D. (1998). Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann. NY Acad. Sci. 854, 78-91.
24. Gundersen, G.G., Khawaja, S., and Bulinski, J.C. (1989). Generation of a stable, posttranslationally modified microtubule array is an early event in myogenic differentiation. J. Cell Biol. 109, 2275-2288.
25. Hagiwara, Y., Sasaoka, T., Araishi, K., Imamura, M., Yorifuji, H., Nonaka, I., Ozawa, E., and Kikuchi, T. (2000). Caveolin-3 deficiency causes muscle degeneration in mice. Hum. Mol. Genet. 9, 3047-3054.
26. Heslop, L., Morgan, J.E., and Partridge, T.A. (2000). Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell Sci. 113(Pt 12), 2299-2308.
27. Hollnagel, A., Grund, C., Franke, W.W., and Arnold, H.H. (2002). The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration. Mol. Cell Biol. 22, 4760-4770.
28. Huber, O., Bierkamp, C., and Kemler, R. (1996). Cadherins and catenins in development. Curr. Opin. Cell Biol. 8, 685-691.
29. Irintchev, A., Zeschnigk, M., Starzinski-Powitz, A., and Wernig, A. (1994). Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev. Dyn. 199, 326-337.
30. Jat, P.S., Noble, M.D., Ataliotis, P., Tanaka, Y., Yannoutsos, N., Larsen, L., and Kioussis, D. (1991). Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA 88, 5096-5100.
31. Kanda, S., Landgren, E., Ljungstrom, M., and Claesson-Welsh, L. (1996). Fibroblast growth factor receptor 1-induced differentiation of endothelial cell line established from tsA58 large T transgenic mice. Cell Growth Differ. 7, 383-395.
32. Kaufmann, U., Kirsch, J., Irintchev, A., Wernig, A., and Starzinski-Powitz, A. (1999). The M-cadherin catenin complex interacts with microtubules in skeletal muscle cells: implications for the fusion of myoblasts. J. Cell Sci. 112(Pt 1), 55-68.
33. Kuch, C., Winnekendonk, D., Butz, S., Unvericht, U., Kemler, R., and Starzinski-Powitz, A. (1997). M-cadherin-mediated cell adhesion and complex formation with the catenins in myogenic mouse cells. Exp. Cell Res. 232, 331-338.
34. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J.E., Hansen, S.H., Nishimoto, I., and Lisanti, M.P. (1995). Evidence for a regulated interaction of hetero-trimeric G proteins with caveolin. J. Biol. Chem. 270, 15693-15701.
35. Li, S., Song, K.S., and Lisanti, M.P. (1996). Expression and characterization of recombinant caveolin: purification by poly-histidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J. Biol. Chem. 271, 568-573.
36. Lisanti, M.P., Scherer, P., Tang, Z.-L., and Sargiacomo, M. (1994). Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol. 4, 231-235.
37. Mangan, M.E., and Olmsted, J.B. (1996). A muscle-specific variant of microtubule-associated protein 4 (MAP4) is required in myogenesis. Development 122, 771-781.
38. Minetti, C. et al. (1998). Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet. 18, 365-368.
39. Moldovan, N., Heltianu, C., Simionescu, N., and Simionescu, M. (1995). Ultrastructural evidence of differential solubility in Triton X-100 of endothelial vesicles and plasma membrane. Exp. Cell Res. 219, 309-313.
40. Morgan, J.E., Beauchamp, J.R., Pagel, C.N., Peckham, M., Ataliotis, P., Jat, P.S., Noble, M.D., Farmer, K., and Partridge, T.A. (1994). Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev. Biol. 162, 486-498.
41. Murata, M., Peranen, J., Schreiner, R., Weiland, F., Kurzchalia, T., and Simons, K. (1995). VIP21/caveolin is a cholesterol-binding protein. Proc. Natl. Acad. Sci. USA 92, 10339-10343.
42. Noble, M., Groves, A.K., Ataliotis, P., Ikram, Z., and Jat, P.S. (1995). The H-2KbtsA58 transgenic mouse: a new tool for the rapid generation of novel cell lines. Transgenic Res. 4, 215-225.
43. Okamoto, T., Schlegel, A., Scherer, P.E., and Lisanti, M.P. (1998). Caveolins, a family of scaffolding proteins for organizing "pre-assembled signaling complexes" at the plasma membrane (Mini-review). J. Biol. Chem. 273, 5419-5422.
44. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M., and Sweeney, H.L. (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710-3714.
45. Renault, V., Piron-Hamelin, G., Forestier, C., DiDonna, S., Decary, S., Hentati, F., Saillant, G., Butler-Browne, G.S., and Mouly, V. (2000). Skeletal muscle regeneration and the mitotic clock. Exp. Gerontol. 35, 711-719.
46. Repetto, S. et al. (1999). Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem. Biophys Res. Commun. 261, 547-550.
47. Saitoh, O., Arai, T., and Obinata, T. (1988). Distribution of microtubules and other cytoskeletal filaments during myotube elongation as revealed by fluorescence microscopy. Cell Tissue Res. 252, 263-273.
48. Sargiacomo, M., Scherer, P.E., Tang, Z.-L., Casanova, J.E., and Lisanti, M.P. (1994). In vitro phosphorylation of caveolin-rich membrane domains: identification of an associated serine kinase activity as a casein kinase II-like enzyme. Oncogene 9, 2589-2595.
49. Sargiacorno, M., Scherer, P.E., Tang, Z.-L., Kubler, E., Song, K.S., Sanders, M.C., and Lisanti, M.P. (1995). Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl. Acad. Sci. USA 92, 9407-9411.
50. Scherer, P.E., Lisanti, M.P., Baldini, G., Sargiacomo, M., Corley-Mastick, C., and Lodish, H.F. (1994). Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J. Cell Biol. 127, 1233-1243.
51. Scherer, P.E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H.F., and Lisanti, M.P. (1996). Identification, sequence and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA 93, 131-135.
52. Scherer, P.E., Tang, Z.-L., Chun, M.C., Sargiacomo, M., Lodish, H.F., and Lisanti, M.P. (1995). Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution: identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem. 270, 16395-16401.
53. Schultz, E., and McCormick, K.M. (1994). Skeletal muscle satellite cells. Rev. Physiol. Biochem. Pharmacol. 123, 213-257.
54. Smart, E., Ying, Y.-S., Conrad, P., and Anderson, R.G.W. (1994). Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J. Cell Biol. 127, 1185-1197.
55. Song, K.S., Li, S., Okamoto, T., Quilliam, L., Sargiacomo, M., and Lisanti, M.P. (1996a). Copurification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent free purification of caveolae membranes. J. Biol. Chem. 271, 9690-9697.
56. Song, K.S., Sargiacomo, M., Galbiati, F., Parenti, M., and Lisanti, M.P. (1997). Targeting of a G alpha subunit (Gil alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation. Cell. Mol. Biol. (Noisy-Le-Grand) 43, 293-303.
57. Song, K.S., Scherer, P.E., Tang, Z.-L., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D.S., and Lisanti, M.P. (1996b). Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem. 271, 15160-15165.
58. Sotgia, F. et al. (2000). Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. identification of a central ww-like domain within caveolin family members. J. Biol. Chem. 275, 38048-38058.
59. Stahlhut, M., and van Deurs, B. (2000). Identification of filamin as a novel ligand for caveolin-1, evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol. Biol. Cell 11, 325-337.
60. Tang, Z.-L., Scherer, P.E., Okamoto, T., Song, K., Chu, C., Kohtz, D.S., Nishimoto, I., Lodish, H.F., and Lisanti, M.P. (1996). Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271, 2255-2261.
61. Turner, P.R., Westwood, T., Regen, C.M., and Steinhardt, R.A. (1988). Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 335, 735-738.
62. Vaghy, P.L., Fang, J., Wu, W., and Vaghy, L.P. (1998). Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett. 431, 125-127.
63. van der Loop, F.T., van der Ven, P.F., Furst, D.O., Gautel, M., van Eys, G.J., and Ramaekers, F.C. (1996). Integration of titin into the sarcomeres of cultured differentiating human skeletal muscle cells. Eur J. Cell Biol. 69, 301-307.
64. van der Ven, P.F., Schaart, G., Croes, H.J., Jap, P.H., Ginsel, L.A., and Ramaekers, F.C. (1993), Titin aggregates associated with intermediate filaments align along stress fiber-like structures during human skeletal muscle cell differentiation. J. Cell Sci. 106(Pt 3), 749-759.
65. Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M.P., Myers, M., and Ishikawa, Y. (1998). Caveolin is an activator of insulin receptor signaling. J. Biol. Chem. 273, 26962-26968.
66. Zeschnigk, M., Kozian, D., Kuch, C., Schmoll, M., and Starzinski-Powitz, A. (1995). Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J. Cell Sci. 108(Pt 9), 2973-2981.